A recent study found that CD155 is highly expressed on macrophages in patients with coronary artery disease (CAD), delivering negative signals to CD4+ T cells expressing CD96 and/or TIGIT receptors [137]. This evidence concerns the gene CD96 and coronary artery disorder.